Jacob Hughes
Stock Analyst at Wells Fargo
(1.43)
# 3,181
Out of 4,829 analysts
27
Total ratings
50%
Success rate
-1.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jacob Hughes
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
AMPH Amphastar Pharmaceuticals | Maintains: Equal-Weight | $40 → $44 | $24.34 | +80.77% | 5 | May 17, 2023 | |
PRGO Perrigo Company | Upgrades: Overweight | $54 | $26.99 | +100.07% | 1 | Sep 6, 2022 | |
IRWD Ironwood Pharmaceuticals | Maintains: Equal-Weight | $12 → $13 | $0.73 | +1,671.60% | 3 | Aug 16, 2022 | |
MDWD MediWound | Maintains: Overweight | $49 → $56 | $18.65 | +200.27% | 1 | May 18, 2022 | |
EBS Emergent BioSolutions | Maintains: Equal-Weight | $46 → $38 | $5.84 | +550.68% | 3 | May 4, 2022 | |
TEVA Teva Pharmaceutical Industries | Maintains: Equal-Weight | $12 → $11 | $17.96 | -38.75% | 11 | Jul 29, 2021 | |
BHC Bausch Health Companies | Maintains: Equal-Weight | $18 → $17 | $4.78 | +255.65% | 3 | Oct 28, 2020 |
Amphastar Pharmaceuticals
May 17, 2023
Maintains: Equal-Weight
Price Target: $40 → $44
Current: $24.34
Upside: +80.77%
Perrigo Company
Sep 6, 2022
Upgrades: Overweight
Price Target: $54
Current: $26.99
Upside: +100.07%
Ironwood Pharmaceuticals
Aug 16, 2022
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $0.73
Upside: +1,671.60%
MediWound
May 18, 2022
Maintains: Overweight
Price Target: $49 → $56
Current: $18.65
Upside: +200.27%
Emergent BioSolutions
May 4, 2022
Maintains: Equal-Weight
Price Target: $46 → $38
Current: $5.84
Upside: +550.68%
Teva Pharmaceutical Industries
Jul 29, 2021
Maintains: Equal-Weight
Price Target: $12 → $11
Current: $17.96
Upside: -38.75%
Bausch Health Companies
Oct 28, 2020
Maintains: Equal-Weight
Price Target: $18 → $17
Current: $4.78
Upside: +255.65%